home / stock / hook / hook news

HOOK News and Press, HOOKIPA Pharma Inc. From 06/19/20

Stock Information
Company Name: HOOKIPA Pharma Inc.
Stock Symbol: HOOK
Market: NASDAQ
Website: hookipapharma.com
Menu
HOOK HOOK Quote HOOK Short HOOK News HOOK Articles HOOK Message Board
Get HOOK Alerts

News, Short Squeeze, Breakout and More Instantly...
HOOK - HOOKIPA Announces Changes to its Board of Directors - Resignation of Sander van Deventer

NEW YORK and VIENNA, Austria, June 19, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that Dr...
HOOK - Hookipa to commence additional arm in HB-201 trial for HPV+ cancers

The FDA clears Hookipa Pharma's (NASDAQ: HOOK ) Investigational New Drug (IND) Application for HB-202, to initiate an additional arm in its Phase 1/2 clinical trial for HB-201 for the treatment of Human Papillomavirus 16-positive (HPV 16 + ) cancers. More news on: HOOKIPA Pharm...

HOOK - HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers

NEW YORK and VIENNA, Austria, June 17, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that the U.S. Food and Drug Admi...

HOOK - HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference

NEW YORK and VIENNA, Austria, May 26, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HOO...
HOOK - HOOKIPA Pharma EPS beats by $0.03, misses on revenue

HOOKIPA Pharma (NASDAQ: HOOK ): Q1 GAAP EPS of -$0.43 beats by $0.03 . More news on: HOOKIPA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HOOK - HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update

NEW YORK and VIENNA, Austria, May 14, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reports its financ...

HOOK - HOOKIPA Pharma To Report First Quarter 2020 Financial Results on May 14, 2020

NEW YORK and VIENNA, Austria, May 04, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that it ...
HOOK - HOOKIPA Pharma to Present at Upcoming Conferences in May

NEW YORK and VIENNA, Austria, April 29, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that H...

HOOK - HOOKIPA Pharma Announces Publication of HB-101 Phase 1 Results in The Journal of Infectious Diseases

NEW YORK and VIENNA, Austria, April 21, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the pu...

HOOK - HOOKIPA Pharma Inc. (HOOK) CEO Joern Aldag on Q4 2019 Results - Earnings Call Transcript

HOOKIPA Pharma Inc. (HOOK) Q4 2019 Earnings Conference Call March 19, 2020, 08:00 AM ET Company Participants Matthew Beck - Executive Director, Investor Relations Joern Aldag - CEO Reinhard Kandera - CFO Igor Matushansky - CMO Roman Necina - CTO Conference Call Participant...
Previous 10 Next 10